Session 1 Panel Discussion

International Hepatitis Cure & Eradication Meeting 2015

A hepatitis C Vaccine: How do we prove it works? | Kimberly Page

International Hepatitis Cure & Eradication Meeting 2015

Hepatitis C Vaccines: Are we making progress? | Christopher M. Walker, PhD

International Hepatitis Cure & Eradication Meeting 2015

HAV in a Tertiary Hospital: 2017 Epidemic vs 2009-2016 Period | Andrea Lombardi, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective | Luz Martin-Carbonero, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective | Massimo Puoti, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

NAFLD in HIV- infected patients | Juan Macías, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Case on HEV | Antonio Rivero-Juarez, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Debate: TDF vs. TAF in HBV management | Douglas Dieterich, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Debate: TDF vs. TAF in HBV management | Mark Nelson, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Decrease in HCV Coinfection in Individuals Newly Diagnosed with HIV-1 in Germany, January 2016 - December 2017 | Patrycja Machnowska

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Characterization of Patients Treated with Hepatitis C - is HIV a Burden? Analysis of an Individual Experience | Cristina Valente

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Epidemiological Characteristics and Factors Contributing to the Development of Liver Fibrosis in HIV/HCV-Coinfected Patients in Ukraine | Tatyana Kyrychenko

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Hepatitis C Diagnostic - Barrier to Effective Linkage to Care within Georgian Hepatitis C Elimination Program | Guranda Jikia, MD, MPH

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

HBV managment in HIV patients | Karine Lacombe, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

HCV care after cure | Raffaele Bruno, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Fibrosis Markers and Cirrhosis management in HIV patients | Marion Peters, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

NAFLD: diagnostics, management and screening | Juan Macías, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Liver care in HIV - management of abnormal LFTs | Juan Berenguer, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

HBV: diagnostics, management and screening | Marion Peters, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

HCV in 2018 | Jürgen Rockstroh, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Regulatory landscape for NASH | Veronica Miller

HEP DART 2017

Aramchol for NASH and beyond: From scientific rationale to clinical development | Carol Brosgart

HEP DART 2017

The Effectiveness of Treatment for Chronic Hepatitis C (and Hepatitis B) in Pediatric Populations | Manal El-Sayed, MD, PhD

HEP DART 2017